Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) EPS (Basic) (2020 - 2025)

NeuroPace (NPCE) has 6 years of EPS (Basic) data on record, last reported at -$0.08 in Q4 2025.

  • For Q4 2025, EPS (Basic) rose 52.94% year-over-year to -$0.08; the TTM value through Dec 2025 reached -$0.66, up 29.03%, while the annual FY2025 figure was -$0.66, 29.03% up from the prior year.
  • EPS (Basic) reached -$0.08 in Q4 2025 per NPCE's latest filing, up from -$0.11 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.08 in Q4 2025 and bottomed at -$32.73 in Q1 2021.
  • Average EPS (Basic) over 5 years is -$1.93, with a median of -$0.33 recorded in 2021.
  • Peak YoY movement for EPS (Basic): skyrocketed 98.9% in 2021, then tumbled 41.18% in 2022.
  • A 5-year view of EPS (Basic) shows it stood at -$0.36 in 2021, then fell by 22.22% to -$0.44 in 2022, then surged by 50.0% to -$0.22 in 2023, then rose by 22.73% to -$0.17 in 2024, then soared by 52.94% to -$0.08 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$0.08 in Q4 2025, -$0.11 in Q3 2025, and -$0.26 in Q2 2025.